G6PD and non-autoimmune hemolytic anemia: Of the 12 patients with acute haemolytic anaemia treated with primaquine, drug-related acute haemolytic anaemia was suspected for seven (58·3%), including one G6PD-intermediate patient (onset day 3, haemoglobin 6·8 g/dL) and six G6PD-deficient patients (onset days 3–6, haemoglobin 4·3–8·1 g/dL).